跳至主要内容
临床试验/NCT07712458
NCT07712458尚未招募不适用

Magnetic Resonance Elastography Assessment Of Chronic Low Back Pain Before And After A Manual Therapy Intervention

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
Mayo Clinic
入组人数
38
试验地点
1
主要终点
Change in SII-derived mobility index

研究概览

简要总结

The purpose of this study is to quantify Magnetic Resonance Elastography (MRE)-derived mechanical property biomarkers of the lumbar paraspinal musculature and associated myofascial tissue regions before and after the intervention.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult males or females (age ≥ 18 years)
  • Report chronic low back pain (≥3 months) (measured by patient history and clinical evaluation)
  • Pain intensity reported at baseline must be ≥4 on the pain VAS scale
  • Presence of myofascial pain features in the lumbar region (e.g., localized tenderness and/or trigger points identified by a qualified clinician/therapist)
  • Able to lie in supine and prone positions for study procedures
  • Be able to participate fully in all aspects of the study
  • Have understood and signed study informed consent

排除标准

  • Pregnancy or breastfeeding
  • Patients with the inability to stay in a prone and supine position for the required procedure durations (e.g., ≥30 minutes at a time)
  • Any contraindication to an MRI exam, or severe claustrophobia that would prevent safe completion of the scan
  • Previous lumbar spine surgery or history of severe lumbar injury (e.g., fracture) that, in the investigation team's judgment, would interfere with participation or safety
  • Patients with known bleeding disorders or current therapeutic anticoagulation that would increase risk of bruising/bleeding with massage
  • Patients with skin conditions affecting the treatment area (e.g., rash, open wound, active dermatitis) or known allergy to any materials used during treatment (e.g., gels/cleaners), if applicable
  • Receipt of a new pain treatment within 3 days of the study visit (e.g., injection, ablation, spinal manipulation, massage/manual therapy) that could confound pre/post measures
  • Use of short-acting opioid analgesics or sedating medications within 24 hours of the study visit
  • Have an implanted device in or near the treatment area that could interfere with safe application of external pressure
  • Have used an investigational drug within 30 days of study enrollment
  • History of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease.
  • Clinically significant unstable neurologic or systemic illness that would preclude safe participation, as judged by the investigation team.
  • Surgical intervention for pain within 1 month prior to enrollment
  • Active infection, wound, or other external trauma to the areas to be treated
  • Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence
  • Inability to provide consent

研究组 & 干预措施

Expert Manipulative Massage Automation (EMMA)

Experimental

Subjects will receive one massage therapy session utilizing the EMMA system

干预措施: EMMA (Expert Manipulative Massage Automation) (Device)

结局指标

主要结局

Change in SII-derived mobility index

时间窗: Baseline, 30 minutes post-intervention

次要结局

  • Change in Pain, Enjoyment of Life, and General Activity (PEG) Scale Score(Baseline, 30 minutes post-intervention)
  • Change in Spinal Range of Motion (ROM)(Baseline, 30 minutes post-intervention)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ziying Yin

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验